Nexeon MedSystems Inc (NXNN)
OTHER OTC:NXNN
US Market
Holding NXNN?
Track your performance easily

Nexeon MedSystems (NXNN) Stock Price & Analysis

50 Followers

NXNN Stock Chart & Stats


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

NXNN FAQ

What was Nexeon MedSystems Inc’s price range in the past 12 months?
Nexeon MedSystems Inc lowest stock price was $0.15 and its highest was $0.30 in the past 12 months.
    What is Nexeon MedSystems Inc’s market cap?
    Currently, no data Available
    When is Nexeon MedSystems Inc’s upcoming earnings report date?
    Nexeon MedSystems Inc’s upcoming earnings report date is Aug 13, 2018 which is 2236 days ago.
      How were Nexeon MedSystems Inc’s earnings last quarter?
      Currently, no data Available
      Is Nexeon MedSystems Inc overvalued?
      According to Wall Street analysts Nexeon MedSystems Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Nexeon MedSystems Inc pay dividends?
        Nexeon MedSystems Inc does not currently pay dividends.
        What is Nexeon MedSystems Inc’s EPS estimate?
        Nexeon MedSystems Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Nexeon MedSystems Inc have?
        Nexeon MedSystems Inc has 1,966,000 shares outstanding.
          What happened to Nexeon MedSystems Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Nexeon MedSystems Inc?
          Currently, no hedge funds are holding shares in NXNN
          ---

          Nexeon MedSystems Stock Smart Score

          Company Description

          Nexeon MedSystems Inc

          Nexeon MedSystems, Inc. is a medical device company, which focuses on the development, manufacturing, and commercialization of neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform has the potential to provide treatment to patients in several established neurostimulator markets including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other emerging neurostimulator markets. The company was founded by Mark C. Bates and Ralph L. Ballard, III in 2005 and is headquartered in Dallas, TX.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          BioSig Technologies
          Stereotaxis
          Lexicon Pharmaceuticals
          MiMedx Group
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis